SCHEMBL6090715

SCHEMBL6090715

Cc1[nH]c(C=C2C(=O)NN=C2c2ccnnc2)c(C(C)C)c1CCCCN(C)C

nearest known ligand 0.42

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KDR P35968 6/20 0.42
CHEK1 O14757 3/20 0.42
SRC P12931 4/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6090703 1.00 KDR (0.42) KDRCHEK1SRCALDH1A1LMNA
SCHEMBL6092623 0.88 KDR (0.41) KDRCHEK1ALDH1A1LMNA
SCHEMBL6092730 0.87 KDR (0.43) KDRCHEK1SRCALDH1A1LMNA
SCHEMBL6092740 0.87 KDR (0.43) KDRCHEK1SRCALDH1A1LMNA
SCHEMBL6090102 0.84 KDR (0.43) KDRCHEK1SRC
SCHEMBL6090092 0.84 KDR (0.43) KDRCHEK1SRC
SCHEMBL6088315 0.84 KDR (0.37) KDRCHEK1
SCHEMBL6088323 0.84 KDR (0.37) KDRCHEK1
SCHEMBL6089354 0.84 KDR (0.47) KDRCHEK1ALDH1A1LMNA
SCHEMBL6089346 0.84 KDR (0.47) KDRCHEK1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218373-A2 2-PYRAZOLIN-5-ONES AS TYROSINE KINASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2002-07-03 EP claimed
WO-2001009121-A2 2-PYRAZOLIN-5-ONES_AS TYROSINE KINASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2001-02-08 WO claimed
US-7060822-B1 2-pyrazolin-5-ones ABBOTT GMBH & CO. KG (DE) 2006-06-13 US disclosed
EP-1218373-A2 2-PYRAZOLIN-5-ONES AS TYROSINE KINASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2002-07-03 EP disclosed
WO-2001009121-A2 2-PYRAZOLIN-5-ONES_AS TYROSINE KINASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2001-02-08 WO disclosed